NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/06/2025
Voltar para busca
Dado oficial do USPTO
LIVITECH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079332314Classe
1, 5, 9, 10, 42, 44
Pedido
79332314
Registro
7117212
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
20/06/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 9, 10, 42, 44
Data de depósito
02/12/2021
Data de registro
25/07/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/07/2023
Última transação
20/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
33
Localização do titular
FR
Examinador
MCGILL, CIERRA
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized wording "LIVITECH" with the letters "LIVI" in dark blue and the word "TECH" in light blue, all to the right of a design of twelve tilted squares with six tilted squares in light blue and six tilted squares in dark blue with the four largest tilted squares in the center connected by straight lines to a smaller tilted square each, with two of the lines in dark blue and two of the lines in light blue. The gray background behind the tilted square design represents shading and/or transparent and is not a feature of the mark.
Titulares e representantes
Titulares
GENFIT
Representantes
Ronald M. Kachmarik Cooper Legal Group, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents for chemical analyses for scientific use; reagents for scientific use; reagents for scientific or medical research use; diagnostic reagents for scientific use; reagents for immunoserology and molecular diagnosis for research use; chemical reagents for genetic research; in-vivo diagnostic reagents for scientific use; diagnostic reagents for scientific use or for research use; diagnostic reagents for in-vitro use in biochemistrymolecular biologyclinical chemistry and microbiology for research use; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Classe 5
Pharmaceuticals for use in human or veterinary medicinefor scientific use for the treatment of inflammatory diseases and liver diseases; chemical preparations for use in human or veterinary medicinefor pharmaceutical usefor the treatment of inflammatory diseases and liver diseases; biological preparations for use in human or veterinary medicinefor pharmaceutical usefor the treatment of inflammatory diseases and liver diseases; preparations for use in human or veterinary medicinefor pharmaceutical usefor the treatment of inflammatory diseases and liver diseases; microorganism cultures for use in human or veterinary medicinefor pharmaceutical use; cell preparations for use in human or veterinary medicinefor pharmaceutical usein particular for gene therapy and cell therapycell growth media; blood and blood derived samplesnamely plasmaserumplatelet free samples for medical use; diagnostic biomarker reagent products for use in human or veterinary medicine; diagnostic reagents for use in human or veterinary medicine; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Classe 9
Downloadable software for use in diagnosis of inflammatory diseases and liver diseases; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments especially for recordingprocessingreproducingtransmitting dataelectronic data loggers and recorders; data processing equipment; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Classe 10
Medical apparatusinstruments and equipmentDNARNA and protein analysis apparatusDNARNA and protein quantifiersmedical devices for measuring DNARNAbiochemical and physical parametersnamely concentration of biomarkers relating to the evaluation of inflammatory and liver diseases and blood analyzers for evaluation of inflammatory and liver diseases; instruments and tools for medical diagnosiscomputer displays and computer monitors and controllers therefor used in direct association with medical diagnosis apparatus during the process of diagnosis of a condition in an individual; diagnostic apparatus for medical usemedical diagnostic apparatus for testing the biomarker levels; all these goods exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Classe 42
Pharmaceutical researchresearch for the discovery of new medicines; scientific researchespecially in the medicalbiomedicalchemicalgeneticpharmaceutical field; basic and applied scientific research; technical scientific research; scientific researchsorting and selection of molecules; scientific research servicesdevelopment and validation of biological testscellular tests and genetic tests; scientific researchfunctional genomics for identifyingcharacterizingvalidating and developing biologically active molecules; analysis of biological substances in biological fluids; computer programming in the field of scientific research and for the pharmaceutical industry; engineering servicessurveying; technical project study being scientific research; professional consultancy unrelated to business dealings in the field of scientific and medical research; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Classe 44
Medical analysis relating to the diagnosis and treatment of persons and medical diagnosis services in inflammatory diseases and liver diseases; medical analyses of blood samplesbiological preparations and biological fluids relating to the diagnosis and treatment of persons; support services in the field of medicinehealth care and pharmaceutical researchmedical analysis for the diagnosis and treatment of patients; medical information; provision of medical information; all these services exclusively in the field of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases; and none of them related to telemedicines servicesonline medical consultation and online medical assistance provided to the public
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/11/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
26/10/2023
FIMP
FINAL DISPOSITION PROCESSED
25/10/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/10/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
25/07/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
25/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
25/07/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/07/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
10/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2023
PUBO
PUBLISHED FOR OPPOSITION
09/05/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
19/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/03/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/03/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/03/2023
RFNT
REFUSAL PROCESSED BY IB
29/03/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/03/2023
GNRT
NON-FINAL ACTION E-MAILED
01/03/2023
CNRT
NON-FINAL ACTION WRITTEN
01/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/01/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
25/01/2023
DOCK
ASSIGNED TO EXAMINER
17/01/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/01/2023
GNFR
FINAL REFUSAL E-MAILED
02/01/2023
CNFR
FINAL REFUSAL WRITTEN
02/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/11/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/10/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/10/2022
RFNT
REFUSAL PROCESSED BY IB
25/05/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/04/2022
RFRR
REFUSAL PROCESSED BY MPU
29/04/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
18/03/2022
CNRT
NON-FINAL ACTION WRITTEN
17/03/2022
DOCK
ASSIGNED TO EXAMINER
17/03/2022
MAFR
APPLICATION FILING RECEIPT MAILED
08/02/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/02/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/02/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIVITECH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.